IperionX Limited (ASX:IPX)

IperionX Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Selling, General & Admin	25.5	13.07	8	6.65	6.26	1.56
Research & Development	16.54	12.57	8.66	5.6	1.08	-
Other Operating Expenses	1.18	1.18	0.21	-	-	-
Operating Expenses	55.34	39.27	22.62	17.66	21.87	8.82
Operating Income	-55.34	-39.27	-22.62	-17.66	-21.87	-8.82
Interest Expense	-2.58	-0.28	-0.12	-0.09	-0.04	-0
Interest & Investment Income	-	2.2	0.55	0.14	0.4	0.01
Currency Exchange Gain (Loss)	1.35	1.35	-0.05	0.35	-	-
Other Non Operating Income (Expenses)	2.95	0.91	0.61	0.06	-0.01	-0
EBT Excluding Unusual Items	-53.62	-35.09	-21.63	-17.19	-21.52	-8.83
Gain (Loss) on Sale of Investments	-	-	-	-0.25	-	-
Gain (Loss) on Sale of Assets	-0.26	-0.26	-0.02	-	-	-
Asset Writedown	-	-	-0.2	-	-	-
Other Unusual Items	-	-	-	-	-	-5.61
Pretax Income	-53.88	-35.35	-21.84	-17.44	-21.52	-14.43
Net Income	-53.88	-35.35	-21.84	-17.44	-21.52	-14.43
Net Income to Common	-53.88	-35.35	-21.84	-17.44	-21.52	-14.43
Shares Outstanding (Basic)	335	297	218	168	135	69
Shares Outstanding (Diluted)	335	297	218	168	135	69
Shares Change (YoY)	35.14%	36.29%	29.65%	24.83%	95.66%	119.52%
EPS (Basic)	-0.16	-0.12	-0.10	-0.10	-0.16	-0.21
EPS (Diluted)	-0.16	-0.12	-0.10	-0.10	-0.16	-0.21
Free Cash Flow	-55.29	-39.41	-26.68	-18.57	-14.95	-4.51
Free Cash Flow Per Share	-0.17	-0.13	-0.12	-0.11	-0.11	-0.07
EBITDA	-52.64	-37.79	-22.49	-17.48	-21.84	-8.82
D&A For EBITDA	2.7	1.48	0.12	0.18	0.03	0
EBIT	-55.34	-39.27	-22.62	-17.66	-21.87	-8.82

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.